Aldesleukin (interleukin-2)
|
Proleukin |
Melanoma and renal cancer treatment |
Anakinra (interleukin 1 (IL1) receptor antagonist) |
Antril, Kineret |
Rheumatoid arthritis treatment |
Calcitonin (salmon calcitonin) |
Fortical |
Post menopausal osteoporosis treatment |
Denileukin diftitox (interleukin-2 and Diphtheria toxin fusioned) |
Ontak |
T-cell lymphoma treatment |
Filgrastim (analog to the granulocyte colony-stimulating factor) |
Neupogen |
Neutropenia treatment (as consequence of AIDS, chemotherapy, bone-among others) |
Filgrastim pegylated |
Neulasta |
Neutropenia treatment (as consequence of AIDS, chemotherapy, bone- marrow transplantation, among others) |
Growth hormone (GH) |
Genotropin, Humatrope, Norditropin, Norivitropin, Nutropin, Omnitrope, Protropin, Siazen, Serostim, Valtropin |
Prader-Willi and Turner syndromes |
Glucagon |
Glucagon |
Hypoglycemia |
Glucarpidase (bacterial carboxypeptidase G2) |
Voraxaze |
Control of methotrexate conc. in patients with deficient renal function |
Insulin (inhalation) |
Exubera |
Diabetes mellitus treatment |
Insulin (fast-acting) |
Lispro |
Diabetes |
Insulin (zinc extended) |
Lente, Ultralente |
Diabetes mellitus treatment |
Interferon-α2a |
Roferon-A |
Chronic hepatitis C. chronic myelogenous leukemia, hairy cell leukemia, Kaposi's sarcoma |
Interferon-α2b |
Intron A |
Chronic hepatitis C. chronic myelogenous leukemia, hairy cell leukemia, Kaposi's sarcoma |
Interferon-α2b pegylated |
Peg-intron |
Chronic hepatitis C. chronic myelogenous leukemia, hairy cell leukemia, Kaposi's sarcoma |
Interferon-β1b |
Betaseron |
Multiple sclerosis |
Interferon-γ1b |
Actimmune |
Chronic granulomatous disease, severe osteopetrosis |
Mecasermin (insulin-like growth factor 1) |
Increlex |
GH and IGF1 deficiencies |
Mecasermin rinfabate (insulin-like growth factor I and its binding protein IGFBP-3) |
iPlex |
GH and IGF1 deficiencies |
Nesiritide (B-type natriuretic peptide) |
Natrecor |
Acute decompensated heart failure (ADHF) treatment |
Oprelvekin (interleukin 11)
|
Neumega |
Prevention of severe thrombocytopenia (patients in chemotherapy) |
OspA (Outer surface protein A fragment from Borrelia burgdorferi) |
LYMerix |
Lyme disease vaccine |
Palifermin (truncade keratinocyte growth factor) |
Kepivance |
Treatment of oral mucositis in (patients undergoing chemotherapy) |
Parathyroid hormone |
Preos, Preotact |
Treatment of osteoporosis and hypoparathyroidism |
Pegvisomant, modified GH (prevent GH binfing to receptor)
|
Somavert |
Acromegaly treatment |
Ranibizumab (Mab fragment) |
Lucentis |
Age related macular degeneration |
Reteplase (plasminogen activator)
|
Rapilysi |
Acute myocardial infarction treatment |
Somatropin, tasonermin |
Humatrope |
hGH deficiency treatment |
Tasonermin (cytokine) |
Beromun |
Soft sarcoma treatment |
Urate oxidase, PEGylated |
Krystexxal |
Gout |
Teriparatide. Parathyroid hormone |
Forteo |
Severe osteoporosis treatment |